Strategic Acquisition CLC recently integrated with Diazyme Laboratories, signaling a shift that may unlock cross-selling opportunities for Diazyme-enabled chemistry workflows, instrument synergies, and expanded geographic reach.

Distribution Expansion Existing distribution agreement with Medline Industries for FDA-cleared fentanyl screening enables rapid access to point-of-care labs nationwide, presenting upsell potential for related reagents, consumables, and rapid test integration.

Veteran Owned & ISO Being privately held, veteran-owned, ISO-certified and FDA-registered strengthens credibility with risk-conscious labs; leverage this for campaigns targeting government contractors, hospital networks, and reference laboratories requiring quality certification.

Diverse Product Line With over 100 general and toxicology reagents and multiple analyzers in service, there are cross-sell opportunities to existing customers by bundling new reagents, validation services, training, and instrument updates.

Growing Market Presence Recent partnerships with Bioeasy’s SMT-120V Veterinary Analyzer and Taiji Medical Supplies indicate a strategy to broaden into veterinary and mobile labs; target expanding mobile clinics, veterinary networks, and allied-health facilities.